Alpine Immune Sciences, Inc.

Leading the Next Evolution of Immunotherapies

Add To Watchlist
General Information
Company Name
Alpine Immune Sciences, Inc.
Founded Year
2015
Location (Offices)
Seattle, United States +1
Founders / Decision Makers
Amanda Enstrom - Senior Director Clinical Biomarkers (Translational Medicine) Mitchell Gold - Co-founder and Executive Chairman Mitchell H. Gold - Co-founder Executive Chairman & CEO Wolfgang Dummer - Chief Medical Officer Kristi Manjarrez - Vice President, Clinical Affairs Remy Durand - Chief Business Officer
Number of Employees
99
Industries
Biotechnology, Health Care
Funding Stage
Post Ipo Equity
Social Media

Alpine Immune Sciences, Inc. - Company Profile

Alpine Immune Sciences, Inc. is a leading player in the biotechnology and health care industries. Founded in 2015, the company has now become a part of Vertex Pharmaceuticals, a global biotechnology company with a focus on transformative medicines for individuals with serious diseases. Alpine Immune Sciences recently received a substantial $150.00M post-IPO equity investment on 06 November 2023, showcasing the interest and confidence of investors in the company's potential. As an analyst, the alignment with a powerhouse like Vertex Pharmaceuticals augurs well for Alpine Immune Sciences, signaling a promising trajectory in the development of next-generation immunotherapies. This strategic integration underlines the significance of Alpine Immune Sciences in the biotech sector as it continues to push boundaries in innovative medical solutions. For further information about Vertex, interested parties can visit https://www.vrtx.com/ and follow Vertex on LinkedIn at https://www.linkedin.com/company/vertex-pharmaceuticals/ for future updates.

Taxonomy: clinical-stage biopharmaceutical, immunotherapy, autoimmune diseases, inflammatory diseases, protein-based therapies, immune synapse targeting, drug development, patented scientific platform, ALPN-303, povetacicept, BAFF antagonist, APRIL antagonist, ALPN-101, acazicolcept, ICOS antagonist

Funding Rounds & Investors of Alpine Immune Sciences, Inc. (7)

View All
Funding Stage Amount No. Investors Investors Date
Post-IPO Equity $150.00M - 06 Nov 2023
Post-IPO Equity $100.00M - 20 Sep 2022
Post-IPO Equity $91.00M 8
Frazier Healthcare Partners, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round OrbiMed, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round Decheng Capital, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round Logos Capital, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round Omega Funds, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round TCG Crossover, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round
Biotechnology Value Fund, Avidity Partners 		15 Sep 2021
Post-IPO Equity $60.00M 4
EcoR1 Capital, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round Omega Funds, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round Samsara BioCapital, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round
Avidity Partners 		24 Jul 2020
Post-IPO Equity $25.00M 5
Frazier Healthcare Partners, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round OrbiMed, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round Decheng Capital, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round Alpine BioVentures, investor in Alpine Immune Sciences, Inc.'s Post-IPO Equity round
Biotechnology Value Fund 		16 Jan 2019

View All 7 Funding Rounds

Latest News of Alpine Immune Sciences, Inc.

View All

No recent news or press coverage available for Alpine Immune Sciences, Inc..

Similar Companies to Alpine Immune Sciences, Inc.

View All
Encysive Pharmaceuticals - Similar company to Alpine Immune Sciences, Inc.
Encysive Pharmaceuticals Leading the fight against vascular and inflammatory diseases with groundbreaking synthetic and small molecule compounds.
Vertex - Similar company to Alpine Immune Sciences, Inc.
Vertex Trade, Earn, Borrow- All in one DEX.
Biopharma-mea - Similar company to Alpine Immune Sciences, Inc.
Biopharma-mea Improving Lives
Arriva Pharmaceuticals - Similar company to Alpine Immune Sciences, Inc.
Arriva Pharmaceuticals Pioneering the future of healthcare with innovative protease inhibitors for diverse therapeutic needs
Ingenium Pharmaceuticals GmbH - Similar company to Alpine Immune Sciences, Inc.
Ingenium Pharmaceuticals GmbH
Circle Decoration Circle Decoration

Want to dive deeper into Alpine Immune Sciences, Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now